Trial Profile
Impact of Everolimus and Ciclosporin Cytomegalovirus (CMV) replication and disease of pediatric kidney allograft recipients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Oct 2016
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Ciclosporin; Mycophenolate mofetil
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 07 Dec 2015 New trial record
- 27 Nov 2015 Results published in the American Journal of Transplantation